Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Annals of Hematology
Published in: Annals of Hematology 11/2019

01-11-2019 | Acidosis | Letter to the Editor

Fatal type B lactic acidosis in a patient with end-stage liver disease related to homozygous sickle cell disease

Authors: Véronique Masy, Etienne Sokal, Nadejda Ranguelov, Bénédicte Brichard, Pierre-François Laterre, Philippe Hantson

Published in: Annals of Hematology | Issue 11/2019

Login to get access

Excerpt

Hepatic involvement by sickle cell disease (SCD) can result in a variety of symptoms ranging from mild to life-threatening. Acute intrahepatic cholestasis is a rare but often fatal condition, with multi-organ failure as a terminal event. The following observation is suggesting that extreme hyperbilirubinemia may be associated with energetic failure. …
Literature
1.
Finsterer J, Scorza FA (2017) Effects of antiepileptic drugs on mitochondrial functions, morphology, kinetics, biogenesis, and survival. Epilepsy Res. 136:5–11CrossRef
2.
Lipka K, Bülow HH (2003) Lactic acidosis following convulsions. Acta Anaesthesiol Scand. 47:616–618CrossRef
3.
Karacaoglu PK, Asma S, Korur A et al (2016) East Mediterranean region sickle cell disease mortality trial: retrospective multicenter cohort analysis of 735 patients. Ann Hematol. 95:993–1000CrossRef
4.
Manci EA, Culberson DE, Yang YM, Gardner TM, Powell R, Haynes J Jr, Shah AK, Mankad VN, Investigators of the Cooperative Study of Sickle Cell Disease (2003) Causes of death in sickle cell disease: an autopsy study. Br J Haematol. 123:359–365CrossRef
5.
Haydek JP, Taborda C, Shah R, Reshamwala PA, McLemore M, Rassi FE, Chawla S (2019) Extreme hyperbilirubinemia: an indicator of morbidity and mortality in sickle cell disease. World J Hepatol. 11:287–293CrossRef
Metadata
Title
Fatal type B lactic acidosis in a patient with end-stage liver disease related to homozygous sickle cell disease
Authors
Véronique Masy
Etienne Sokal
Nadejda Ranguelov
Bénédicte Brichard
Pierre-François Laterre
Philippe Hantson
Publication date
01-11-2019
Publisher
Springer Berlin Heidelberg
Published in
Annals of Hematology / Issue 11/2019
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-019-03822-8

Other articles of this Issue 11/2019

Annals of Hematology 11/2019 Go to the issue

Letter to the Editor

Epstein–Barr virus–associated post-transplant lymphoproliferative disorder among long-term survivors of adults after single cord blood transplantation without antithymocyte globulin

Letter to the Editor

ASXL2 mutation is recurrent in non-de novo AML1-ETO-negative acute myeloid leukemia

Original Article

Pixantrone demonstrates significant in vitro activity against multiple myeloma and plasma cell leukemia

Letter to the Editor

Primary intraocular natural killer-cell lymphoma successfully treated using a multidisciplinary strategy

Original Article

Hematocrit levels and thrombotic events in patients with polycythemia vera: an analysis of Veterans Health Administration data

Original Article

Efficacy and safety of micafungin in unrelated cord blood transplant recipients
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits